Aatmaj Healthcare Limited

AATMAJ NSE Healthcare Hospital
₹26.75
+0.75%
Delayed · cached 15 min

Fair value analysis

AATMAJ
Aatmaj Healthcare Limited
HealthcareHospital
₹18.15
Close used for this calculation
₹9.15Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
16/100
Profitability4/25
Returns3/25
Balance Sheet9/25
Efficiency0/25
Growth0/25
Weak
Quality radar
16Prof.4/25Ret.3/25Eff.0/25B.Sht9/25Growth0/25

Consensus fair value

₹9.15
Above FV
▼ -49.6% against the close used
Model range ₹3.24 – ₹15.90
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹3.24Fair value₹9.15Bull₹15.90
FairClose
52-week traded range
52W low ₹17.7552W high ₹25.25

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Aatmaj Healthcare Limited closed at ₹18.15, 98.4% above the consensus fair value of ₹9.15 drawn from 7 valuation models.

Financial DNA score 16/100 — Weak. P/E of 58.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹5.81
-68.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹12.58
-30.7%
√(22.5 × EPS × BVPS)
EPS=0.31, BVPS=22.69 · outside Graham range (P/E 58.4, P/B 0.8) — asset-light, treat as a rough floor
P/E Fair Value
₹15.90
-12.4%
EPS × 51.3x (sector P/E)
EPS=0.31, Sector P/E=51.3x
EV/EBITDA
₹3.89
-78.6%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=30M
Book Value (P/B)
₹3.24
-82.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=22.69, ROE=1.4%, g=3%, r=10%
Reverse DCF
₹18.15
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 21.7% | Historical: 0%
Margin of Safety
₹8.57
-52.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=11.43, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.